EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitLeitlinieOpen Access · CC BY-NC 4.0

The Overview of Practical Guidelines for Gliomas by KSNO, NCCN, and EANO

Young Zoon Kim iD, Chae-Yong Kim iD, Do Hoon Lim iD

Brain Tumor Research and Treatment · 2022 · 10 (2) · 83

DOI: 10.14791/btrt.2022.0001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Brain Tumor Research and Treatment, 2022. Verfasst von Young Zoon Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurooncology and Department of Neurosurgery, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gliomas have been histologically diagnosed as the third most common primary tumor of the central nervous system (CNS) in a relatively small portion of Korea. Despite the rarity of gliomas, the disease entity is very dynamic due to its various molecular characteristics, compared with other CNS tumors. The practice of managing glioma patients is not globally established as a precise standard guideline because of the different socio-medical environments of individual countries. The Korean Society for Neuro-Oncology (KSNO) published guidelines for managing adult glioma in 2019, and the National Comprehensive Cancer Network and European Association of Neuro-Oncology published guidelines in September 2021 and March 2021, respectively. However, these guidelines have several different recommendations in practice, including tissue management, adjuvant treatment after surgical resection, and salvage treatment for recurrent/progressive gliomas. Currently, the KSNO guideline working group is preparing an updated version of the guideline for managing adult gliomas. In this review, common features have been verified and different points are analyzed. Consequently, this review is expected to be informative and helpful to provide high quality evidence and a strong recommendation level for the establishment of new KSNO guidelines for managing gliomas.

Schlagwörter

Stichwörter der Autor:innen

GliomasGuidelineKSNOPractice

Autor:innen und Institutionen

  • Division of Neurooncology and Department of Neurosurgery, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea.
  • Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
  • Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. dh8lim@skku.edu.

ORCID-Profile: Young Zoon Kim, Chae-Yong Kim, Do Hoon Lim

Zitieren

APA

Kim, Y. Z., Kim, C. Y., & Lim, D. H. (2022). The Overview of Practical Guidelines for Gliomas by KSNO, NCCN, and EANO. Brain Tumor Research and Treatment, 10(2), 83. https://doi.org/10.14791/btrt.2022.0001

Vancouver

Kim YZ, Kim CY, Lim DH. The Overview of Practical Guidelines for Gliomas by KSNO, NCCN, and EANO. Brain Tumor Research and Treatment. 2022;10(2):83. doi:10.14791/btrt.2022.0001

BibTeX
@article{Kim2022,
  author = {Kim, Young Zoon and Kim, Chae-Yong and Lim, Do Hoon},
  title = {The Overview of Practical Guidelines for Gliomas by KSNO, NCCN, and EANO},
  journal = {Brain Tumor Research and Treatment},
  year = {2022},
  volume = {10},
  number = {2},
  pages = {83},
  doi = {10.14791/btrt.2022.0001}
}
Kostenlos starten →